Posttranscriptional regulation of mRNA is a powerful and tightly controlled process in which cells command the integrity, diversity, and abundance of their protein products. RNA-binding proteins (RBPs) are the principal players that control many intermediary steps of posttranscriptional regulation. Recent advances in this field have discovered the importance of RBPs in hematological diseases. Herein we will review a number of RBPs that have been determined to play critical functions in leukemia and lymphoma. Furthermore, we will discuss the potential therapeutic strategies that are currently being studied to specifically target RBPs in these diseases.
CITATION STYLE
Prieto, C., & Kharas, M. G. (2020). RNA regulators in leukemia and lymphoma. Cold Spring Harbor Perspectives in Medicine, 10(5). https://doi.org/10.1101/cshperspect.a034967
Mendeley helps you to discover research relevant for your work.